SE8403179D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE8403179D0 SE8403179D0 SE8403179A SE8403179A SE8403179D0 SE 8403179 D0 SE8403179 D0 SE 8403179D0 SE 8403179 A SE8403179 A SE 8403179A SE 8403179 A SE8403179 A SE 8403179A SE 8403179 D0 SE8403179 D0 SE 8403179D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- sub
- carbon atoms
- alkyl
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8403179A SE8403179D0 (sv) | 1984-06-13 | 1984-06-13 | New compounds |
US06/739,425 US4636499A (en) | 1984-06-13 | 1985-05-30 | Sulphenamides |
EP85850199A EP0171372B1 (fr) | 1984-06-13 | 1985-06-06 | Sulfénamides, procédés pour leur préparation et leur utilisation dans la préparation de compositions pharmaceutiques |
DE8585850199T DE3565406D1 (en) | 1984-06-13 | 1985-06-06 | Sulphenamides, processes for their preparation and their use in the manufacture of pharmaceutical preparations |
AT85850199T ATE37719T1 (de) | 1984-06-13 | 1985-06-06 | Sulphenamide, verfahren zur herstellung von diesen verbindungen und verwendung von obengenannten verbindungen zur herstellung von pharmazeutischen praeparaten. |
JP60126398A JPH0696581B2 (ja) | 1984-06-13 | 1985-06-12 | 新規なスルフエンアミド |
US06/913,689 US4725691A (en) | 1984-06-13 | 1986-09-30 | 2-[8-quinolinyl]-sulphinyl-1H-benzimidazole |
JP5268822A JPH0739412B2 (ja) | 1984-06-13 | 1993-10-27 | 新規なスルホキシド |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8403179A SE8403179D0 (sv) | 1984-06-13 | 1984-06-13 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE8403179D0 true SE8403179D0 (sv) | 1984-06-13 |
Family
ID=20356221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8403179A SE8403179D0 (sv) | 1984-06-13 | 1984-06-13 | New compounds |
Country Status (6)
Country | Link |
---|---|
US (2) | US4636499A (fr) |
EP (1) | EP0171372B1 (fr) |
JP (2) | JPH0696581B2 (fr) |
AT (1) | ATE37719T1 (fr) |
DE (1) | DE3565406D1 (fr) |
SE (1) | SE8403179D0 (fr) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
GB8505492D0 (en) * | 1985-03-04 | 1985-04-03 | Roussel Lab Ltd | Chemical compounds |
CA1276017C (fr) * | 1986-02-13 | 1990-11-06 | Takeda Chemical Industries, Ltd. | Derives de sulfenamide, et leur production |
EP0239129B1 (fr) * | 1986-03-28 | 1991-09-25 | Otsuka Pharmaceutical Co., Ltd. | Composés hydroquinoléine, compositions les contenant et procédé pour leur préparation |
AU604771B2 (en) * | 1986-09-27 | 1991-01-03 | Fisons Plc | Pyridinylphenylthio and pyridinylphenylsulphinyl benzimidazone derivatives |
WO1989010927A1 (fr) * | 1988-05-12 | 1989-11-16 | Eisai Co., Ltd. | Sel de pyridinium et preparation pharmacologique le contenant |
US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
SI9700186B (sl) * | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US20030021849A1 (en) * | 2001-04-09 | 2003-01-30 | Ben-Zion Dolitzky | Polymorphs of fexofenadine hydrochloride |
CA2444456A1 (fr) * | 2001-04-09 | 2002-10-17 | Teva Pharmaceutical Industries Ltd. | Polymorphes de chlorhydrate de fexofenadine |
JP2005521662A (ja) * | 2002-01-25 | 2005-07-21 | サンタラス インコーポレイティッド | プロトンポンプ阻害剤の経粘膜送達 |
WO2003104197A1 (fr) * | 2002-06-10 | 2003-12-18 | Teva Pharmaceutical Industries Ltd. | Forme polymorphe xvi de l'hydrochlorure de fexofenadine |
JP2006518751A (ja) * | 2003-02-20 | 2006-08-17 | サンタラス インコーポレイティッド | 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物 |
JP2006188432A (ja) * | 2003-02-25 | 2006-07-20 | Zeria Pharmaceut Co Ltd | 四環系スルフェンアミド化合物 |
US20050031700A1 (en) * | 2003-07-18 | 2005-02-10 | Sanatarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
CA2531564C (fr) * | 2003-07-18 | 2016-01-19 | Santarus, Inc. | Formulations pharmaceutiques utilisees pour inhiber une secretion acide et procede de fabrication associe |
US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
CA2561700A1 (fr) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique |
MXPA06012281A (es) * | 2004-04-26 | 2007-07-18 | Teva Pharma | Formas cristalinas de clorhidrato de fexofenadina y procesos para su preparacion. |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1685106A2 (fr) * | 2004-09-28 | 2006-08-02 | Teva Pharmaceutical Industries, Inc. | Forme de cristal de fexofenadine et ses processus de preparation |
WO2008067037A2 (fr) | 2006-10-05 | 2008-06-05 | Santarus, Inc. | Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
WO2008047681A1 (fr) | 2006-10-13 | 2008-04-24 | Eisai R & D Management Co., Ltd. | Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique |
EP2086543A2 (fr) | 2006-10-27 | 2009-08-12 | The Curators of the University of Missouri | Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
JP2011512416A (ja) | 2008-02-20 | 2011-04-21 | ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ | オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法 |
JP6322644B2 (ja) | 2012-11-26 | 2018-05-09 | エムキュア ファーマシューティカルズ リミテッド | 酸分泌阻害薬としてのピリドン誘導体およびその製造方法 |
WO2024075017A1 (fr) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition de calcification de valve aortique |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
-
1984
- 1984-06-13 SE SE8403179A patent/SE8403179D0/xx unknown
-
1985
- 1985-05-30 US US06/739,425 patent/US4636499A/en not_active Expired - Lifetime
- 1985-06-06 EP EP85850199A patent/EP0171372B1/fr not_active Expired
- 1985-06-06 AT AT85850199T patent/ATE37719T1/de not_active IP Right Cessation
- 1985-06-06 DE DE8585850199T patent/DE3565406D1/de not_active Expired
- 1985-06-12 JP JP60126398A patent/JPH0696581B2/ja not_active Expired - Lifetime
-
1986
- 1986-09-30 US US06/913,689 patent/US4725691A/en not_active Expired - Lifetime
-
1993
- 1993-10-27 JP JP5268822A patent/JPH0739412B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH06316573A (ja) | 1994-11-15 |
EP0171372A1 (fr) | 1986-02-12 |
US4636499A (en) | 1987-01-13 |
JPH0696581B2 (ja) | 1994-11-30 |
US4725691A (en) | 1988-02-16 |
EP0171372B1 (fr) | 1988-10-05 |
JPS617281A (ja) | 1986-01-13 |
JPH0739412B2 (ja) | 1995-05-01 |
DE3565406D1 (en) | 1988-11-10 |
ATE37719T1 (de) | 1988-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8403179D0 (sv) | New compounds | |
MX154758A (es) | Procedimiento para preparacion de derivados de succinimida | |
NO152130C (no) | Analogifremgangsmaate for fremstilling av bronchospasmolytisk virksomme forbindelser | |
ES528157A0 (es) | Un procedimiento para la preparacion de dihidropiridinas. | |
SE7709865L (sv) | Nya fenyletylaminer och forfarande for framstellning derav | |
GB1430729A (en) | Arylamino pyrimidinic derivatives their process ff preparation and their therapeutic application | |
ATE67193T1 (de) | 6-phenyl-pyridazin-verbindungen. | |
ES2056073T3 (es) | Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende. | |
SE7709158L (sv) | Nya substituerade 2-fenylaminoimidazolin-(2)-er, syraadditionssalter derav, lekemedel som innehaller dessa och forfarande for framstellning derav | |
DE3070847D1 (en) | Benzazepine derivatives, process and intermediates for their preparation, their use and pharmaceutical compositions containing them | |
ES2058275T3 (es) | Derivados biciclicos de sulfonamida y su preparacion, su uso y formulaciones que los contienen. | |
ATE22065T1 (de) | Alkan- und alkenderivate und ihre herstellung und verwendung. | |
ATE43841T1 (de) | 1,5-diphenylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
IT1193608B (it) | Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico | |
KR910006310A (ko) | 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체 | |
NO165593C (no) | Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater. | |
ES8801202A1 (es) | Un procedimiento para preparar derivados de alcanoles aroma-ticos heteropoliciclicos | |
GB2133012B (en) | Quinazolines process for their preparation and pharmaceutical compositions containing them | |
SE7713779L (sv) | Nya fenylderivat | |
FR2379505A1 (fr) | Nouveaux produits doues notamment de proprietes therapeutiques, leurs procedes de preparation, et medicaments a base de ces produits | |
JPS5711970A (en) | Quinazolinone compound and its preparation | |
Morton Jr et al. | Inter-oxa-13, 14-dihydro-PGD 1 compounds | |
Peterson et al. | 12, 13 (E)-Didehydro-13, 14-dihydro-PGD 2 compounds | |
ES477280A1 (es) | Procedimiento para la obtencion de un diastereomero especi- fico de eritro-2-(2-aralquilamino-1-hidroxietil)-1,4-benzo- dioxanos. | |
GB1457256A (en) | 1-phenoxy-2-formyloxy-3-2-cyanochromonyloxy-propanes |